Thomas Emm

996 total citations
16 papers, 694 citations indexed

About

Thomas Emm is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Thomas Emm has authored 16 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Thomas Emm's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Pharmacological Effects and Assays (3 papers). Thomas Emm is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Pharmacological Effects and Assays (3 papers). Thomas Emm collaborates with scholars based in United States. Thomas Emm's co-authors include Swamy Yeleswaram, William V. Williams, Naresh Punwani, Xuejun Chen, Yvonne Lo, Peggy Scherle, Jack Shi, Ryan McGee, Fiona Lee and George L. Drusano and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Drug Metabolism and Disposition and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Thomas Emm

16 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Emm United States 11 254 219 168 158 157 16 694
Charles R.J. Singer United Kingdom 17 112 0.4× 419 1.9× 22 0.1× 186 1.2× 269 1.7× 40 964
Oliver Bruhn Germany 13 72 0.3× 80 0.4× 21 0.1× 262 1.7× 198 1.3× 16 675
Paul G. Killenberg United States 15 58 0.2× 56 0.3× 94 0.6× 156 1.0× 151 1.0× 28 1.1k
Marius Dohse Germany 9 128 0.5× 180 0.8× 56 0.3× 230 1.5× 497 3.2× 13 788
Amina Haouala Switzerland 11 195 0.8× 272 1.2× 79 0.5× 146 0.9× 145 0.9× 18 591
Muhammad Baluom United States 17 115 0.5× 94 0.4× 72 0.4× 116 0.7× 101 0.6× 20 781
George Tang United States 14 49 0.2× 189 0.9× 27 0.2× 256 1.6× 201 1.3× 39 837
Stanley S. Levinson United States 13 53 0.2× 170 0.8× 35 0.2× 334 2.1× 51 0.3× 55 946
Leonard H. Brubaker United States 12 85 0.3× 106 0.5× 45 0.3× 269 1.7× 120 0.8× 23 677
Yoshitane Kosaka Japan 15 24 0.1× 155 0.7× 30 0.2× 176 1.1× 80 0.5× 53 971

Countries citing papers authored by Thomas Emm

Since Specialization
Citations

This map shows the geographic impact of Thomas Emm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Emm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Emm more than expected).

Fields of papers citing papers by Thomas Emm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Emm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Emm. The network helps show where Thomas Emm may publish in the future.

Co-authorship network of co-authors of Thomas Emm

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Emm. A scholar is included among the top collaborators of Thomas Emm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Emm. Thomas Emm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Shi, Jack, Xuejun Chen, Fiona Lee, et al.. (2014). The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers. The Journal of Clinical Pharmacology. 54(12). 1354–1361. 164 indexed citations
2.
Chen, Xuejun, Jack Shi, Thomas Emm, et al.. (2013). Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patients. Clinical Pharmacology in Drug Development. 3(1). 34–42. 27 indexed citations
3.
Shi, Jack, Xuejun Chen, Ryan McGee, et al.. (2011). The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers. The Journal of Clinical Pharmacology. 51(12). 1644–1654. 123 indexed citations
4.
Li, Yu, Thomas Emm, & Swamy Yeleswaram. (2011). Simultaneous determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by LC‐MS/MS using supported liquid extraction. Biomedical Chromatography. 25(11). 1245–1251. 25 indexed citations
5.
Shi, Jack, Xuejun Chen, Thomas Emm, et al.. (2011). The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers. The Journal of Clinical Pharmacology. 52(6). 809–818. 86 indexed citations
6.
Shilling, Adam D., Frank M. Nedza, Thomas Emm, et al.. (2010). Metabolism, Excretion, and Pharmacokinetics of [14C]INCB018424, a Selective Janus Tyrosine Kinase 1/2 Inhibitor, in Humans. Drug Metabolism and Disposition. 38(11). 2023–2031. 86 indexed citations
7.
Wu, Steven T., et al.. (2001). High-performance liquid chromatographic assay for the determination of 2′-deoxy-3′-thiacytidine (lamivudine) in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 761(2). 195–201. 33 indexed citations
8.
9.
Emm, Thomas, et al.. (1996). Determination of naltrexone and its major metabolite, 6-β-naltrexol, in human plasma using liquid chromatography with electrochemical detection. Journal of Pharmaceutical and Biomedical Analysis. 14(12). 1717–1725. 32 indexed citations
10.
Emm, Thomas, et al.. (1996). Determination of XR510, a balanced angiotensin II receptor antagonist, in dog and rat plasma by combined liquid-liquid/solid-phase extraction and high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 675(2). 273–278. 1 indexed citations
11.
Wu, Steven T., Herman F. Stampfli, Thomas Emm, et al.. (1994). Determination of DMP 728, a receptor antagonist, in rat and dog plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography B Biomedical Sciences and Applications. 657(1). 254–260. 2 indexed citations
12.
Emm, Thomas, et al.. (1991). Update on the physical-chemical compatibility of cromolyn sodium nebulizer solution: bronchodilator inhalant solution admixtures.. PubMed. 66(2). 185–9. 10 indexed citations
13.
Emm, Thomas, et al.. (1988). High-performance liquid chromatographic assay of cephalexin in serum and urine. Journal of Chromatography B Biomedical Sciences and Applications. 427(1). 162–165. 4 indexed citations
14.
Emm, Thomas, et al.. (1988). Determination of albuterol in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 427(1). 188–194. 30 indexed citations
15.
Emm, Thomas, et al.. (1987). Simultaneous determination of doxepin and nordoxepin in serum using high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 419. 445–451. 4 indexed citations
16.
Drusano, George L., Matthew R. Weir, Alan Forrest, et al.. (1987). Pharmacokinetics of intravenously administered ciprofloxacin in patients with various degrees of renal function. Antimicrobial Agents and Chemotherapy. 31(6). 860–864. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles R.J. Singer Breakdown of academic impact, for papers by Oliver Bruhn Breakdown of academic impact, for papers by Paul G. Killenberg Breakdown of academic impact, for papers by Marius Dohse Breakdown of academic impact, for papers by Amina Haouala Breakdown of academic impact, for papers by Muhammad Baluom Breakdown of academic impact, for papers by George Tang Breakdown of academic impact, for papers by Stanley S. Levinson Breakdown of academic impact, for papers by Leonard H. Brubaker Breakdown of academic impact, for papers by Yoshitane Kosaka
Rankless by CCL
2026